Shanghai Eye Disease Prevention and Treatment Center Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2019
NCT03949101
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Jiannan Huang | Shanghai Eye Disease Prevention and Treatment Center